Matches in SemOpenAlex for { <https://semopenalex.org/work/W2099259117> ?p ?o ?g. }
- W2099259117 endingPage "429" @default.
- W2099259117 startingPage "409" @default.
- W2099259117 abstract "Therapy for patients with chronic myeloid leukaemia has grown in complexity, first with the advent of the prototype ABL kinase inhibitor, imatinib, and subsequently with the availability of alternate (currently second-line) inhibitors. Imatinib, dasatinib and nilotinib each have specific considerations regarding safety and toxicity, in addition to a limited number common to the class of ABL kinase inhibitors. Optimal management of patients on therapy requires intimate knowledge not only of response criteria and of timing but also of potential toxicities and their basis, best approaches to avoid them, strategies to manage them when identified and how they may affect response to therapy and patient outcome. With the availability of several approved kinase inhibitors and the ongoing development of additional therapies for Philadelphia chromosome positive (Ph+) leukaemias, there is increasing incorporation of toxicity considerations into decision making between agents. This article reviews the toxicities related to the currently available ABL inhibitors – their basis, relevance and management." @default.
- W2099259117 created "2016-06-24" @default.
- W2099259117 creator A5015789771 @default.
- W2099259117 creator A5041829729 @default.
- W2099259117 date "2009-09-01" @default.
- W2099259117 modified "2023-10-18" @default.
- W2099259117 title "Management of Drug Toxicities in Chronic Myeloid Leukaemia" @default.
- W2099259117 cites W1592992878 @default.
- W2099259117 cites W1964358866 @default.
- W2099259117 cites W1980084789 @default.
- W2099259117 cites W1980663284 @default.
- W2099259117 cites W1982545047 @default.
- W2099259117 cites W1986453044 @default.
- W2099259117 cites W1986635169 @default.
- W2099259117 cites W1994309500 @default.
- W2099259117 cites W1997499809 @default.
- W2099259117 cites W1998356799 @default.
- W2099259117 cites W1998990808 @default.
- W2099259117 cites W1999277101 @default.
- W2099259117 cites W2004492241 @default.
- W2099259117 cites W2008933596 @default.
- W2099259117 cites W2010195142 @default.
- W2099259117 cites W2014839361 @default.
- W2099259117 cites W2020367573 @default.
- W2099259117 cites W2025173384 @default.
- W2099259117 cites W2031327569 @default.
- W2099259117 cites W2032164094 @default.
- W2099259117 cites W2035160863 @default.
- W2099259117 cites W2035492623 @default.
- W2099259117 cites W2038672401 @default.
- W2099259117 cites W2039201527 @default.
- W2099259117 cites W2039771828 @default.
- W2099259117 cites W2041655620 @default.
- W2099259117 cites W2043694799 @default.
- W2099259117 cites W2050894854 @default.
- W2099259117 cites W2054251966 @default.
- W2099259117 cites W2055515709 @default.
- W2099259117 cites W2057058781 @default.
- W2099259117 cites W2057718276 @default.
- W2099259117 cites W2060971515 @default.
- W2099259117 cites W2063684828 @default.
- W2099259117 cites W2065725554 @default.
- W2099259117 cites W2066099870 @default.
- W2099259117 cites W2068639674 @default.
- W2099259117 cites W2069502117 @default.
- W2099259117 cites W2070683532 @default.
- W2099259117 cites W2073035156 @default.
- W2099259117 cites W2076378952 @default.
- W2099259117 cites W2080125373 @default.
- W2099259117 cites W2080907164 @default.
- W2099259117 cites W2083373229 @default.
- W2099259117 cites W2091653492 @default.
- W2099259117 cites W2094447725 @default.
- W2099259117 cites W2098666353 @default.
- W2099259117 cites W2099465692 @default.
- W2099259117 cites W2100537270 @default.
- W2099259117 cites W2104899243 @default.
- W2099259117 cites W2107268345 @default.
- W2099259117 cites W2114627676 @default.
- W2099259117 cites W2116153687 @default.
- W2099259117 cites W2119010176 @default.
- W2099259117 cites W2119761223 @default.
- W2099259117 cites W2120033838 @default.
- W2099259117 cites W2126579741 @default.
- W2099259117 cites W2140385618 @default.
- W2099259117 cites W2148738557 @default.
- W2099259117 cites W2151968496 @default.
- W2099259117 cites W2154169171 @default.
- W2099259117 cites W2163773009 @default.
- W2099259117 cites W2167790621 @default.
- W2099259117 cites W2171188310 @default.
- W2099259117 cites W2171722798 @default.
- W2099259117 cites W2246670699 @default.
- W2099259117 cites W2329648702 @default.
- W2099259117 cites W2507771140 @default.
- W2099259117 cites W2513438748 @default.
- W2099259117 cites W2548581615 @default.
- W2099259117 cites W2552508548 @default.
- W2099259117 cites W2564702211 @default.
- W2099259117 cites W2587257066 @default.
- W2099259117 cites W2587858544 @default.
- W2099259117 cites W2909054803 @default.
- W2099259117 cites W4235458680 @default.
- W2099259117 cites W4248586401 @default.
- W2099259117 cites W4255034461 @default.
- W2099259117 cites W51538918 @default.
- W2099259117 doi "https://doi.org/10.1016/j.beha.2009.06.001" @default.
- W2099259117 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19959091" @default.
- W2099259117 hasPublicationYear "2009" @default.
- W2099259117 type Work @default.
- W2099259117 sameAs 2099259117 @default.
- W2099259117 citedByCount "45" @default.
- W2099259117 countsByYear W20992591172012 @default.
- W2099259117 countsByYear W20992591172013 @default.
- W2099259117 countsByYear W20992591172014 @default.
- W2099259117 countsByYear W20992591172015 @default.
- W2099259117 countsByYear W20992591172016 @default.
- W2099259117 countsByYear W20992591172017 @default.